Coding and Reimbursement

Similar documents
Medicare Part C Medical Coverage Policy

THE LINK BETWEEN FDA APPROVAL OF MEDICAL DEVICES AND REIMBURSEMENT

INSTITUTE OF MEDICINE COMMITTEE ON THE DETERMINATION OF ESSENTIAL HEALTH BENEFITS

Zimmer Payer Coverage Approval Process Guide

Anthem Provider Appeal Policy and Procedure

The Fundamentals of Reimbursement

Coverage and Billing Issues for Clinical Research

Coding and Reimbursement Guide

SUMMARY OF BENEFITS $500 ** Effective from January 1, 2016 through December 31, 2016 Insured by Cigna Health and Life Insurance Company

MEDICAL DEVICE REIMBURSEMENT PRESENTED AT ST. THOMAS UNIVERSITY, DESIGN AND MANUFACTURING IN THE MEDICAL DEVICE INDUSTRY COURSE ON SEPTEMBER 30, 2013

Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze

HUMANA, INC. AND HUMANA HEALTH PLAN, INC. SETTLEMENT OVERVIEW

Global Days Policy, Professional

Radiation Therapy Services

Intensity Modulated Radiation Therapy Policy

SUMMARY OF MARYLAND STATE EMPLOYEES & RETIREES BEHAVIORAL HEALTH PLAN

SUMMARY OF MARYLAND STATE EMPLOYEES & RETIREES MENTAL HEALTH AND SUBSTANCE ABUSE PLAN

Cigna Administrative Policy

General Who is National Imaging Associates, Inc. (NIA)?

And the Beat goes on Authorizations and Reimbursement for VADs

Lucentis(Ranibizumab)

SUMMARY OF MARYLAND STATE EMPLOYEES & RETIREES BEHAVIORAL HEALTH PLAN

The Changing Landscape of Medicare's Clinical Trial Coverage Policies for Medical Devices. Michael Sanchez, M.A., CCA Reimbursement Advisor

Medicare National Coverage Determinations (NCD) and Local Coverage Determinations (LCD) for Clinical Trials

NEWSFLASH: Quorum Consulting s Guide to the Medicare Clinical Diagnostics Laboratory Tests Payment System Final Rule.

2017 Hospital Outpatient Prospective Payment System Final Rule Summary

Clinical Trials Corporate Medical Policy

Medicare Part C Medical Coverage Policy

MEDICAL PHYSICS ECONOMICS UPDATE. CMS Proposed Rules for Medicare. Medicare Part B. Medicare Part A. Medicare Part C.

Discarded Drugs and Biologicals

2018 Abbott Reimbursement Guide and FAQ CardioMEMS HF System Effective January 1, 2018

HEALTH ECONOMICS AND REIMBURSEMENT

Ace Left Brain Stimulation Device Strategy for Medicare Coverage and Payment

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For Aetna New York Providers Performing Physical Medicine Services

Frequently Asked Questions Radiology Prior Authorization Program for the UnitedHealthcare Community Plan, Arizona

Cedars-Sinai Medical Group Downstream Provider Notice CLAIMS SETTLEMENT PRACTICES & DISPUTE RESOLUTION MECHANISM

9/17/2018. Non-covered services. Description: Billing for services not covered under the Medicare program

4/29/2014. April 30, 2014

SUMMARY OF BENEFITS. Alliance Behavioral Healthcare Open Access Plus Plan Effective 7/1/12. Cigna Health and Life Insurance Co.

Policies and Procedures: WVU Physicians of Charleston Medicare Advance Beneficiary Notice of Noncoverage

SUMMARY OF BENEFITS. Montgomery College Open Access Plus Coinsurance Plan. Connecticut General Life Insurance Co. Notice of Grandfathered Plan Status

Clinical Policy: Pralatrexate (Folotyn) Reference Number: CP.PHAR.313 Effective Date: Last Review Date: 11.18

A Guide to Hospital Billing for Transprostatic Implant Using the UroLift System. The UroLift System Reimbursement Support

Commercial Insurance

Objectives: Reduce Reimbursement Risk

Table of Contents. 1.0 Description of the Procedure, Product, or Service Definitions... 1

Billing and Payment. To register, call UHC-FAST ( ) or your local Evercare provider representative.

Features that Add Value. Freedom of Choice. Quality Service Is Part of Quality Care

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Understanding the Insurance Process

Frequently Asked Questions Cardiology Prior Authorization Program Applies to UnitedHealthcare Community Plan Members.

Glossary of Terms (Terms are listed in Alphabetical Order)

CHAPTER 12 SECTION 2.1 TRICARE OVERSEAS PROGRAM (TOP) - COSTS AND UNIFORM HMO BENEFITS

PROFESSIONAL CLAIMS CODE EDITING AND DOCUMENTATION REQUIREMENTS GUIDELINES Updated April 22, 2009

Profilnine is indicated for: Prevention and control of bleeding in patients with factor IX deficiency (hemophilia B).

Radiation Oncology Clinical Coverage Policy No.: 1K-6 Amended Date: October 1, 2015 Table of Contents

ADDENDUM TO PARTICIPATING PHYSICIAN, PHYSICIAN GROUP AND PHYSICIAN ORGANIZATION CONTRACT

Overview of Coverage of Drugs Under the Medicaid Medical Benefit

Solera 5.5/6.0mm Fenestrated Screw Set. CD Horizon DEVICE DESCRIPTION INDICATIONS FOR USE REIMBURSEMENT GUIDE

Impact of Work RVU Changes. Impact of PE RVU Changes. Total $93,149 0% 0% 0% 0% $1,745 0% 1% 0% 1%

General Ophthalmological Services Clinical Coverage Policy No: 1T-1 Amended Date: October 1, Table of Contents

Contractor Information. LCD Information. FUTURE Local Coverage Determination (LCD): Molecular Diagnostic Tests (MDT) (L33541)

BATH COMMUNITY HOSPITAL FINANCIAL REPORT

I. Determine practitioner(s) or groups eligible to participate in the Physician UPL Supplemental Payment program.

Magellan Healthcare 1 Frequently Asked Questions (FAQ s) For Gateway Health Medicare Assured Providers

HEALTHCARE COMMON PROCEDURE CODING SYSTEM (HCPCS) LEVEL II CODING PROCEDURES

See Important Reminder at the end of this policy for important regulatory and legal information.

Session 3 Medical Technology and Healthcare Policy Payment perspectives

Reimbursement for Advanced Diagnostics: Challenges and Opportunities

Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Archived SECTION 14 - SPECIAL DOCUMENTATION REQUIREMENTS. Section 14 - Special Documentation Requirements

Meet the Presenter. Welcome to PMI s Webinar Presentation. On the topic: Maximizing the Use of LCDs & NCDs

See Important Reminder at the end of this policy for important regulatory and legal information.

From Research to Revenue Coverage and Reimbursement for Life Sciences Products

VIRGINIA ACTS OF ASSEMBLY SESSION

SUMMARY OF BENEFITS. Unlimited. Lifetime Maximum Applies to all Part A and Part B expenses. Unlimited

What Your Plan Covers and How Benefits are Paid BENEFIT PLAN. Prepared Exclusively for Carey International, Inc. High Deductible Choice POS II

CHAPTER 3 Section 4, pages 1 and 2 Section 4, pages 1 and 2. CHAPTER 20 Section 2, pages 3 through 8 Section 2, pages 3 through 8

See Important Reminder at the end of this policy for important regulatory and legal information.

2019 HOUSE OF DELEGATES Medical Society of the State of New York Report of Recommendations for Sunset of Policy Adopted 2009

Reopening and Redetermination Submissions

RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT DIVISION OF WORKERS COMPENSATION

WEA Trust Health Conversion Plan

Milliman RBRVS for Hospitals

WORKERS COMPENSATION REFORMS OFFICIAL MEDICAL FEE SCHEDULE PHYSICIAN SERVICES SUMMARY CHANGES TO THE OFFICIAL MEDICAL FEE SCHEDULE PHYSICIAN SERVICES

Zimmer Computer-Assisted Surgery Reimbursement Kit

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical Policy: Irinotecan Liposome (Onivyde) Reference Number: CP.PHAR.304 Effective Date: Last Review Date: 11.18

Adult Preventive Medicine Clinical Coverage Policy No.: 1A-2 Annual Health Assessment Amended Date: October 1, 2015.

Prior Authorization for Outpatient Injectable Chemotherapy Frequently Asked Questions

Understanding Private Payers & Maximizing Private Payer Reimbursement Strategies: Understanding the Process

Medicare Part A Quarterly Updates. Palmetto GBA JM A/B MAC Provider Outreach & Education September 13, 2017

What are the chances that I might be diagnosed with cancer?

See Important Reminder at the end of this policy for important regulatory and legal information.

General Who is National Imaging Associates, Inc. (NIA)?

8. Third-Party Payment Policies

Patient Credit and Collections Policy. Penn State Health Revenue Cycle

The Impact of Future Healthcare Reform on MedTech Communications

General Who is National Imaging Associates, Inc. (NIA)?

1. Women s Health and Cancer Rights Act of 1998 (WHCRA)

Transcription:

Coding and Reimbursement IORT Reimbursement Kathy Francisco The Pinnacle Health Group, Inc., Pennsylvania

The statements of the healthcare professional giving this presentation reflect only their personal opinions and experiences and do not necessarily reflect the opinions of any institution with whom they are affiliated. The healthcare professional giving this presentation has no contractual relationship with Carl Zeiss Meditec, Inc., and has received no compensation for these statements. The following presentation may include discussion of device features and applications that are not FDA cleared in the United States.

IORT Reimbursement Kathy Francisco The Pinnacle Health Group, Inc. kfran@thepinnaclehealthgroup.com

Key Reimbursement Elements Coding Identifies the products and procedures performed by the physician Provides the payer information to determine coverage and payment Coverage Defines the criteria that must be met for a payer to deem services and procedures medically necessary for a patient Payment Payment represents the value the payer places on the service or supply provided

Coding Treatment Delivery o CPT Category I code effective 2012 77424 Intraoperative radiation treatment delivery, x-ray, single treatment session Report treatment planning and physics codes separately in addition to 77424 Applicator Placement/Removal o Temporary coding available for applicator placement/removal C9728 Placement and removal (if performed) of applicator into breast for radiation therapy xxx99 Miscellaneous (other body sites) o February 2016 - CPT application submitted by ASBS for permanent applicator placement/removal coding - breast

Coverage Policy developed by payer to determine if services or codes would be deemed appropriate for a beneficiary (patient) based upon supporting clinical literature and medical necessity Positive Policy o Written policy guidelines that indicate the conditions under which coverage will be permitted Silent Policy o No written policy guidelines o Coverage/Medical necessity and payment (if approved) will be determined at claim submission Negative Policy o Written guidelines that do not permit coverage o Treatment is deemed experimental and investigational

General Coverage Requirements Medicare o FDA approval or clearance o Reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member (Social Security Act 1862(a)) Private payers o FDA approval or clearance for indication or use o Significant peer reviewed and published scientific evidence demonstrating efficacy of procedure/technology Use of technology improves net health outcomes o Must be as beneficial as established alternatives (comparison to gold standard) o Use must be generally recognized by health care providers across the country o Acceptance of technology by professional medical societies (inclusion in standard protocols)

IORT Coverage Snapshot Medicare (12 Jurisdictions managed by 8 contractors) o 11 jurisdictions silent No specific coverage policies that address IORT (77424) Coverage is determined when claim is submitted and processed o Palmetto GBA considers IORT experimental/investigational Negative coverage in North Carolina, South Carolina, Virginia, West Virginia Private Payers (53 plans) o National plans Aetna Positive for Cervical/Colorectal/Soft tissue/uterine only Anthem Positive for IORT as boost for Colorectal/Pancreatic/Pelvic/Soft tissue/breast CIGNA - Investigational UHC Positive for breast o Regional plans Most plans silent o Coverage is determined when claim is submitted and processed Some plans provide coverage for certain indications/sites with specific criteria outlined Breast is not typically NOT covered but may be considered for boost only

Payment IORT Breast 2016 Estimated Medicare Revenue 2016 National Values Hospital Physician CPT Description Units SI 2016 Medicare 2016 Medicare Per Treatment Per Treatment 19301 Partial lumpectomy 1 T packaged 673.48 C9726 Placement of breast applicator - rigid 1 N N/A N/A 19499 Unlisted Procedure, Breast (placement of breast applicator) 1 T N/A By Report 77261 Therapeutic radiology treatment planning; simple 1 B N/A 76.62 77280 Simulation, simple 1 S packaged 36.52 77300 Basic dosimetry calculation 1 S packaged 32.58 77332 Treatment devices, design and construction; simple 1 S packaged 28.66 77370 Special medical physics consult 1 S packaged 0 77424 Intraoperative radiation tx delivery, x-ray, single tx session 1 *J1 7,557.75 0 77469 Intraoperative radiation treatment management 1 B N/A 325.82 Estimated Per Treatment Revenue: $7,557.75 $1,173.68 Surgeon $673.48 Radiation Oncologist $423.58 +19499 by report *All services on the claim are packaged with the primary "J1" service for the claim, except services with SI "F, G, H, L, & U"

Summary and Key Issues Coding + Coding for IORT available and stable since 2012 - Coding for applicator placement/removal required CPT application submitted for breast Coverage ± Silent coverage by most plans - Coverage limited by indication/body site - Coverage limited to boost - Need to address coverage with Medicare MAC GBA and private plans (supporting literature) Payment + Positive Medicare payment + Non-Medicare plan payment appropriate when covered

The 2016 U.S. INTRABEAM User Meeting has been sponsored by ZEISS. Not all products, services or offers referenced in this presentation are approved or offered in every market and approved labeling and instructions may vary from one country to another. SUR.7806